Colorectal Cancer Treatments and Studies -- 专题文献

专题：Colorectal Cancer Treatments and Studies

This cluster of papers represents advancements in the research and treatment of colorectal cancer, focusing on topics such as the use of cetuximab and bevacizumab, the impact of KRAS and BRAF mutations, the efficacy of chemotherapy, and the development of molecular subtypes for precision medicine. It also explores the role of EGFR inhibitors and the molecular mechanisms underlying metastatic colorectal cancer.

专题：Colorectal Cancer Treatments and Studies

最新文献

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer

Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma

Cancer stem cell-driven drug resistance in colorectal carcinoma: molecular aspects and therapeutic potentials

Novel immune-nutritional prognostic ratio predicts long-term survival in stage I–III colorectal cancer

KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance

The prognostic role of inflammation-based hematologic markers in stage I–III colorectal cancer: a retrospective analysis

近5年高被引文献